Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SUCLG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RNF34 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
WDFY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGA2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC66 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAATS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PROK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102725051 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TOP2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYLK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCND3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506418 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STARD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKAP8L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NTRK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on